D
Roivant Sciences Ltd. ROIV
$10.66 $0.242.30%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 169.38M -- 95.30M -151.12M 5.10B
Total Depreciation and Amortization 1.94M -- 4.88M 5.23M 2.52M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -325.47M -- -212.01M 21.48M -5.33B
Change in Net Operating Assets -53.11M -- -81.00M 15.96M 21.20M
Cash from Operations -207.25M -- -192.83M -108.46M -210.45M
Capital Expenditure -1.83M -- -965.00K -349.00K -355.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures 154.44M -- -- -804.00K 5.23B
Other Investing Activities 301.46M -- -- 8.08M 0.00
Cash from Investing 454.07M -- -965.00K 6.93M 5.23B
Total Debt Issued -- -- -- -- --
Total Debt Repaid -49.09M -- -1.83M -7.67M -7.66M
Issuance of Common Stock 28.12M -- 2.27M 3.66M 8.88M
Repurchase of Common Stock -251.98M -- -661.06M -28.61M -3.31M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 0.00 238.73M
Cash from Financing -272.95M -- -660.62M -32.62M 236.64M
Foreign Exchange rate Adjustments -1.07M -- -2.74M -855.00K 3.04M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -27.20M -- -857.15M -135.01M 5.26B
Weiss Ratings